OBJECTIVE To Address challenges in clinical care, quality improvement, research, and
public policy for prenatally opioid-exposed neonates by standardizing the clinical definition …

Objective: The purpose of this study was to critically analyze the role of stigma in the care of
pregnant and parenting individuals with opioid use disorder (OUD) through the theoretical …

Neonatal abstinence syndrome (NAS) is a significant public health problem in the United
States. The most commonly used tool to assess and treat infants with NAS is the Finnegan …

Opioids are potent analgesics used to manage pain in both young and old, but the
increased use in the pregnant population has significant individual and societal implications …

Background Newborns with prenatal opioid exposure (POE) are commonly diagnosed with
neonatal abstinence/opioid-withdrawal syndromes due to characteristic symptoms and overt …

OBJECTIVE We examined weight loss patterns and feeding practices of infants hospitalized
for neonatal opioid withdrawal syndrome (NOWS) managed by the eat, sleep, console …

BACKGROUND AND OBJECTIVE Methadone and morphine are commonly administered
medications for neonatal opioid withdrawal syndrome (NOWS). Infants are increasingly …

BACKGROUND The prevalence of opioid use disorder and medication-assisted treatment in
pregnancy is increasing. Compared with term infants, preterm infants have a lower …

The opioid epidemic in the United States has increased opioid use in women of reproductive
age, leading to in utero exposure causing withdrawal symptoms in newborns known as …

Introduction: Infants diagnosed with neonatal abstinence syndrome [NAS] or neonatal opioid
withdrawal syndrome [NOWS] is a growing population in Canada. In most facilities, an …